These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1272119)

  • 41. Risks of third-trimester amniocentesis.
    Zalud I; Janas S
    J Reprod Med; 2008 Jan; 53(1):45-8. PubMed ID: 18251361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perinatal outcome after recent cocaine usage.
    Mastrogiannis DS; Decavalas GO; Verma U; Tejani N
    Obstet Gynecol; 1990 Jul; 76(1):8-11. PubMed ID: 2359569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the fetal biophysical profile in severe oligohydramnios after preterm premature rupture of the membranes.
    Hovick TJ; Vintzileos AM; Bors-Koefoed R; Campbell WA; Rodis JF; Nochimson DJ
    J Reprod Med; 1989 May; 34(5):353-6. PubMed ID: 2732983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes.
    Maymon E; Romero R; Chaiworapongsa T; Kim JC; Berman S; Gomez R; Edwin S
    Am J Obstet Gynecol; 2001 Nov; 185(5):1143-8. PubMed ID: 11717648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes.
    Shim SS; Romero R; Hong JS; Park CW; Jun JK; Kim BI; Yoon BH
    Am J Obstet Gynecol; 2004 Oct; 191(4):1339-45. PubMed ID: 15507963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the feto-maternal transfusion of red blood cells during transplacental and para-placental genetic amniocenteses (author's transl)].
    Zach HP; Zahn V; Herzog B; Stühmer M
    Geburtshilfe Frauenheilkd; 1979 May; 39(5):378-83. PubMed ID: 456859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A survey of pregnancies complicated by decreased amniotic fluid.
    Mercer LJ; Brown LG; Petres RE; Messer RH
    Am J Obstet Gynecol; 1984 Jun; 149(3):355-61. PubMed ID: 6731513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of twin-twin transfusion syndrome in pregnancies with iatrogenic detachment of membranes following therapeutic amniocentesis and the role of interim amniopatch.
    Quintero RA; Kontopoulos EV; Chmait R; Bornick PW; Allen M
    Ultrasound Obstet Gynecol; 2005 Nov; 26(6):628-33. PubMed ID: 16217744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complications of third-trimester amniocentesis using continuous ultrasound guidance.
    Gordon MC; Narula K; O'Shaughnessy R; Barth WH
    Obstet Gynecol; 2002 Feb; 99(2):255-9. PubMed ID: 11814506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomised trial of progesterone prophylaxis after midtrimester amniocentesis.
    Corrado F; Dugo C; Cannata ML; Di Bartolo M; Scilipoti A; Carlo Stella N
    Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):196-8. PubMed ID: 11750964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety of amniocentesis in relation to site and method.
    Gunston KD; Davey DA
    S Afr Med J; 1978 Sep; 54(12):492-3. PubMed ID: 734582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplacental amniocentesis: is it really a higher-risk procedure?
    Giorlandino C; Mobili L; Bilancioni E; D'Alessio P; Carcioppolo O; Gentili P; Vizzone A
    Prenat Diagn; 1994 Sep; 14(9):803-6. PubMed ID: 7845887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The closure of iatrogenic membrane defects after amniocentesis and endoscopic intrauterine procedures.
    Young BK; Roman AS; MacKenzie AP; Stephenson CD; Minior V; Rebarber A; Timor-Tritsch I
    Fetal Diagn Ther; 2004; 19(3):296-300. PubMed ID: 15067244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks' gestation.
    Brumfield CG; Lin S; Conner W; Cosper P; Davis RO; Owen J
    Obstet Gynecol; 1996 Jul; 88(1):114-8. PubMed ID: 8684742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amniocentesis: indications and complications.
    Vrettos AS; Koliopoulos C; Panayotou PP
    Int Surg; 1975 Feb; 60(2):101-3. PubMed ID: 1116906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fetomaternal transfusions in complicated and uncomplicated pregnancy].
    du Bois A; Rasenack R; Dziekan G; Siebers JW; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):443-9. PubMed ID: 1716239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suprapubic vs. periumbilical amniocentesis.
    Gordon HR; Deukmedjian AG
    Am J Obstet Gynecol; 1975 Jun; 122(3):287-90. PubMed ID: 1130452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The risks of amniocentesis in the management of premature rupture of the membranes.
    Yeast JD; Garite TJ; Dorchester W
    Am J Obstet Gynecol; 1984 Jul; 149(5):505-8. PubMed ID: 6742019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Feto-maternal microtranfusion after amniocentesis in the 2nd trimenon (author's transl)].
    Schultze-Mosgau H; Lehmann F
    Med Klin; 1976 Jan; 71(2):60-2. PubMed ID: 1246217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimizing the risk of amniocentesis for prenatal diagnosis.
    Goldstein AI; Dumars KW
    JAMA; 1977 Mar; 237(13):1336-8. PubMed ID: 402491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.